These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 37324485)
1. Intranasal cerium oxide nanoparticles improves locomotor activity and reduces oxidative stress and neuroinflammation in haloperidol-induced parkinsonism in rats. Mohammad ; Khan UA; Warsi MH; Alkreathy HM; Karim S; Jain GK; Ali A Front Pharmacol; 2023; 14():1188470. PubMed ID: 37324485 [No Abstract] [Full Text] [Related]
2. Intranasal inorganic cerium oxide nanoparticles ameliorate oxidative stress induced motor manifestations in haloperidol-induced parkinsonism. Mohammad ; Khan UA; Saifi Z; Bora J; Warsi MH; Abourehab MAS; Jain GK; Kesharwani P; Ali A Inflammopharmacology; 2023 Oct; 31(5):2571-2585. PubMed ID: 37432554 [TBL] [Abstract][Full Text] [Related]
3. Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson's disease. Usama Ashhar M; Vyas P; Vohora D; Kumar Sahoo P; Nigam K; Dang S; Ali J; Baboota S Int J Pharm; 2022 Apr; 618():121683. PubMed ID: 35314276 [TBL] [Abstract][Full Text] [Related]
4. Selegiline Nanoformulation in Attenuation of Oxidative Stress and Upregulation of Dopamine in the Brain for the Treatment of Parkinson's Disease. Kumar S; Dang S; Nigam K; Ali J; Baboota S Rejuvenation Res; 2018 Oct; 21(5):464-476. PubMed ID: 29717617 [TBL] [Abstract][Full Text] [Related]
5. Effect of Cerium Oxide Nanoparticles on Oxidative Stress Biomarkers in Rats' Kidney, Lung, and Serum. Sepanjnia A; Ghasemi H; Mohseni R; Ranjbar A; Shabani F; Salimi F; Kheiripour N Iran Biomed J; 2020 Jul; 24(4):251-6. PubMed ID: 32306723 [TBL] [Abstract][Full Text] [Related]
6. Experimental validation of Vitex negundo leaves hydroalcoholic extract for neuroprotection in haloperidol induced parkinson's disease in rat. Vannur A; Biradar PR; Patil V Metab Brain Dis; 2022 Feb; 37(2):411-426. PubMed ID: 35023027 [TBL] [Abstract][Full Text] [Related]
7. Nano-ropinirole for the management of Parkinsonism: blood-brain pharmacokinetics and carrier localization. Mustafa G; Ahuja A; Al Rohaimi AH; Muslim S; Hassan AA; Baboota S; Ali J Expert Rev Neurother; 2015 Jun; 15(6):695-710. PubMed ID: 25955028 [TBL] [Abstract][Full Text] [Related]
8. Characterization and Therapeutic Potential of Curcumin-Loaded Cerium Oxide Nanoparticles for Interstitial Cystitis Management. Lin YC; Liang YJ; Zhang CH; Liu LJ; Lin FH Antioxidants (Basel); 2024 Jul; 13(7):. PubMed ID: 39061895 [TBL] [Abstract][Full Text] [Related]
9. Protective effect of cerium oxide nanoparticles on cisplatin and oxaliplatin primary toxicities in male albino rats. Abdelhamid AM; Mahmoud SS; Abdelrahman AE; Said NM; Toam M; Samy W; Amer MA Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2411-2425. PubMed ID: 32710137 [TBL] [Abstract][Full Text] [Related]
10. Designing lisuride intranasal nanocarrier system for reduction of oxidative damage with enhanced dopamine level in brain for Parkinsonism. Kumar S; Gupta SK; Pahwa R J Psychiatr Res; 2023 Sep; 165():205-218. PubMed ID: 37517241 [TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effects of oral and intraperitoneal administration of cerium oxide nanoparticles on experimental hepatic ischemia-reperfusion injury. Zengin A; Erikçi A; Telli G; Gümüşel B; Kösemehmetoğlu K; Uçar G; Cem Algın M Turk J Surg; 2022 Sep; 38(3):255-265. PubMed ID: 36846057 [TBL] [Abstract][Full Text] [Related]
12. Sol-gel synthesis and cytotoxicity evaluation of selenium-doped cerium oxide nanoparticles for biomedical applications. Javid H; Amiri H; Hashemi SF; Reihani A; Esparham A; Hashemy SI Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3437-3447. PubMed ID: 37962586 [TBL] [Abstract][Full Text] [Related]
13. Cerium Oxide Nanoparticles Alleviate Neuropathic Pain by Modulating Macrophage Polarization in a Rat SCI Model. Ban D; Yu H; Xiang Z; Li C; Yu P; Wang J; Liu Y J Pain Res; 2022; 15():3369-3380. PubMed ID: 36317164 [TBL] [Abstract][Full Text] [Related]
15. CCRD based development of bromocriptine and glutathione nanoemulsion tailored ultrasonically for the combined anti-parkinson effect. Ashhar MU; Kumar S; Ali J; Baboota S Chem Phys Lipids; 2021 Mar; 235():105035. PubMed ID: 33400967 [TBL] [Abstract][Full Text] [Related]
16. Intranasal galantamine/chitosan complex nanoparticles elicit neuroprotection potentials in rat brains via antioxidant effect. Kandil LS; Farid RM; ElGamal SS; Hanafy AS Drug Dev Ind Pharm; 2021 May; 47(5):735-740. PubMed ID: 34032549 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of toxicological and antioxidant potential of Nardostachys jatamansi in reversing haloperidol-induced catalepsy in rats. Rasheed AS; Venkataraman S; Jayaveera KN; Fazil AM; Yasodha KJ; Aleem MA; Mohammed M; Khaja Z; Ushasri B; Pradeep HA; Ibrahim M Int J Gen Med; 2010 May; 3():127-36. PubMed ID: 20531975 [TBL] [Abstract][Full Text] [Related]
18. Gallic acid and/or cerium oxide nanoparticles synthesized by gamma-irradiation protect cisplatin-induced nephrotoxicity via modulating oxidative stress, inflammation and apoptosis. Saif-Elnasr M; El-Ghlban S; Bayomi AI; El-Sayyad GS; Maghraby MS Arch Biochem Biophys; 2023 May; 740():109594. PubMed ID: 37023935 [TBL] [Abstract][Full Text] [Related]
19. Cerium oxide nanoparticles: potential applications for cancer and other diseases. Wason MS; Zhao J Am J Transl Res; 2013; 5(2):126-31. PubMed ID: 23573358 [TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting. Kumbhar SA; Kokare CR; Shrivastava B; Gorain B; Choudhury H Int J Pharm; 2020 Aug; 586():119499. PubMed ID: 32505580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]